Cart
sales@molnova.com
Home - Products - Others - Other Targets - (Rac)-EC5026

(Rac)-EC5026

CAS No. 1809885-55-9

(Rac)-EC5026( —— )

Catalog No. M37677 CAS No. 1809885-55-9

(Rac)-EC5026 ((Rac)-BPN-19186) is a potent piperidine inhibitor of soluble epoxide hydrolase (sEH) with a Ki of 0.06 nM, useful for research on Parkinson's disease and dementia with Lewy Bodies (DLB) .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 88 Get Quote
5MG 141 Get Quote
10MG 226 Get Quote
25MG 365 Get Quote
50MG 522 Get Quote
100MG 691 Get Quote
500MG 1386 Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    (Rac)-EC5026
  • Note
    Research use only, not for human use.
  • Brief Description
    (Rac)-EC5026 ((Rac)-BPN-19186) is a potent piperidine inhibitor of soluble epoxide hydrolase (sEH) with a Ki of 0.06 nM, useful for research on Parkinson's disease and dementia with Lewy Bodies (DLB) .
  • Description
    (Rac)-EC5026 ((Rac)-BPN-19186) is a potent piperidine inhibitor of soluble epoxide hydrolase (sEH) extracted from patent WO2019156991A1, page 39, has a Ki of 0.06 nM. (Rac)-EC5026 can be used for the research ofParkinson's disease and dementia with Lewy Bodies (DLB).
  • In Vitro
    (Rac)-EC5026 inhibits soluble epoxide hydrolase (sEH), with a Ki of 0.06 nM.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Epoxide Hydrolase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1809885-55-9
  • Formula Weight
    405.39
  • Molecular Formula
    C18H23F4N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (616.69 mM; Ultrasonic )
  • SMILES
    CCC(C)C(=O)N1CCC(CC1)NC(=O)Nc1ccc(OC(F)(F)F)c(F)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hammock BD, et, al. Methods of inhibiting formation of alpha synuclein aggregates. WO2019156991A1.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Quizalofop

    Quizalofop is a reagent of biochemical.

  • RET-IN-1

    RET-IN-1 is a RET kinase inhibitor extracted from patent WO2018071447A1, Compound Example 552.

  • Cadazolid

    Cadazolid is an oxazolidinone-type antibiotic, with activity against gram-positive bacteria, including Clostridium difficile.

Sign In Join Free